Germany jurisdiction report: First compulsory licence for a pharma product
The case concerns European patent number EP 1 422 218, which protects an antiviral agent that can be used for a pharmaceutical composition for treating HIV infections. During opposition proceedings the patent was upheld in limited form in the first instance before the European Patent Office (EPO). An appeal against this decision is still pending before
the EPO.
